Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Telenomus podisi

ABSTRACT: Telenomus podisi Transcriptome or Gene expression

PROVIDER: PRJNA246261 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR1274857.fastq.gz	Fastqsanger.gz
	SRR1274858.fastq.gz	Fastqsanger.gz

Items per page:

1 - 2 of 2

Similar Datasets

Telenomus remus

Project description:Telenomus remus overview

| PRJNA791095 | ENA

Telenomus remus

Project description:Telenomus remus Raw sequence reads

| PRJNA1260750 | ENA

Telenomus remus isolate:Trem-ZJU

Project description:Telenomus remus isolate:Trem-ZJU Genome sequencing and assembly

| PRJNA723667 | ENA

Trehalose accumulation strategy enhancing cold stress response in Telenomus remus, a dominant egg parasitoid of Spodoptera frugiperda

Project description:<p>Telenomus remus, an egg parasitoid capable of penetrating multi-layered egg masses, has emerged as a promising candidate for the biological control of Spodoptera frugiperda. Nevertheless, our prior investigations have uncovered that its limited cold tolerance represents a critical bottleneck in mass rearing. To overcome this challenge, the overarching objectives were to identify candidate genes and metabolites associated with cold tolerance, investigate the dynamic changes of cryoprotectants under different stress conditions, and elucidate the cold tolerance mechanisms of T. remus. The results revealed that the survival rates of T. remus declined progressively as temperature decreased. Notably, a significant accumulation of trehalose was observed as the stress temperature decreased. Integrated multi-omics analysis indicated that the starch and sucrose metabolism pathway played a key role in mediating cold tolerance in T. remus. Within this metabolic pathway, the expression levels of GAA (α-glucosidase) and GYS (glycogen synthase) exhibited a clear temperature-dependent upregulation trend. Collectively, these findings suggest that T. remus adopted a cold-tolerance strategy centered around trehalose accumulation. These research advances our understanding of the molecular and biochemical foundations of cold adaptation in T. remus, while also highlighting trehalose-mediated osmotic regulation as a prioritized research direction for future ectotherm thermotolerance studies.</p>

2025-06-09 | MTBLS12473 | MetaboLights

Project description:Sequencing for Telenomus remus

| PRJNA1056913 | ENA

The mitochondrial genome of <i>Telenomus remus</i> (Hymenoptera: Platygastridae).

Project description:Telenomus remus Nixon, 1937 is an important parasitoid of lepidopterans. We sequenced the mitochondrial genome of T. remus, 15,500 bp in size, and possessed all 37 typical mitochondrial genes. A few tRNAs show gene arrangements compared with the ancestral gene order, mainly involving in the four tRNA clusters (E-C-Y-Q-I-A, D-K, N-F-S1-R, and M-V). The nucleotide sequences of 13 protein-coding genes of this sequence and another seven species from Platygastridae were used for phylogenetic analysis by MrBayes, with two species from Cynipoidea as an outgroup. The topology demonstrated that T. remus was most closely related to Telenomus sp.

| S-EPMC7971337 | biostudies-literature

Biomarks of Resistance to Cetuximab in Colorectal Cancer

Project description:Interventions: A group:Before using cetuximab;B group:After progression of disease:no Primary outcome(s): KRAS gene sequence;NRAS gene sequence;BRAF gene sequence;PIK3CA gene sequence;EGFR gene sequence;EGFR gene copy numbers;EGFR expression;Her2 expression;c-Met expression;PTEN expression Study Design: historical control

| 2671639 | ecrin-mdr-crc

Telenomus sp. AD-2014

Project description:The 1KITE project: evolution of insects

| PRJNA252183 | ENA

TR study of ‘multicenter Phase II study to evaluate efficacy and safety of combination therapy with trastuzumab and pertuzumab in patients with HER2-positive metastatic colorectal cancer&quot

Project description:Primary outcome(s): Cancer-related gene alteration, expression of protein, and expression of RNA

| 2645675 | ecrin-mdr-crc

TR study of ‘A multicenter phase II study of eribulin monotherapy in patients with BRAF V600E mutant metastatic colorectal cancer (BRAVERY study)&quot

Project description:Primary outcome(s): cancer-related gene alteration, gene expression, microsatellite instability, BRAF mutant allele frequency

| 2646701 | ecrin-mdr-crc